Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A patient with complete hair loss regrew all her hair using tofacitinib.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Upadacitinib improved multiple immune-related conditions in one patient.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ruxolitinib cream may help treat severe hair loss in children.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Cancer prevention has advanced significantly, with some strategies proving successful.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.